Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 117, Issue 1, 2014, Pages 125-131

  Champ, Colin E ^a,b   Palmer, Joshua D ^b   Volek, Jeff S ^c   Werner Wasik, Maria ^b   Andrews, David W ^b   Evans, James J ^b   Glass, Jon ^b   Kim, Lyndon ^b   Shi, Wenyin ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

High grade glioma; Ketogenic diet; Radiation therapy; Temozolomide

Indexed keywords

DEXAMETHASONE; GLUCOSE; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER SURVIVAL; CHEMORADIOTHERAPY; DIET RESTRICTION; DRUG MEGADOSE; FATIGUE; GLIOBLASTOMA; GLUCOSE BLOOD LEVEL; HUMAN; KETOGENIC DIET; MAJOR CLINICAL STUDY; METABOLISM; RETROSPECTIVE STUDY; SAFETY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD GLUCOSE; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; DEXAMETHASONE; FOLLOW-UP STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; KETOGENIC DIET; KETONES; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84901625233     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1362-0     Document Type: Article

References (31)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996. doi: 10.1056/NEJMoa043330
2. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
3. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H (1990) Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170:223-230
4. Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol 19:17-24. doi: 10.1016/j.semcancer.2008.11.006
5. Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C, Dusing RW, Machtay M (2010) FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2:19. doi: 10.1186/1758-3284-2-19
6. Maurer GD, Brucker DP, Bahr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J (2011) Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer 11:315. doi: 10.1186/1471-2407-11-315
7. Seyfried TN, Kiebish M, Mukherjee P, Marsh J (2008) Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia 49:114-116. doi: 10.1111/j.1528-1167.2008.01853.x
8. Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27:1082-1086. doi: 10.1200/JCO.2008.19.1098
9. McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, Olivi A, Quinones-Hinojosa A (2008) Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 63:286-291. doi: 10.1227/01.NEU. 0000315282.61035.48
10. Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA (2012) Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 28:1028-1035. doi: 10.1016/j.nut.2012.05.001
11. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR (2001) Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 38:519-527. doi: 10.1016/s0197-0186(00)00102-9
12. Nehlig A (2004) Brain uptake and metabolism of ketone bodies in animal models. Prostaglandins Leukot Essent Fatty Acids 70:265-275. doi: 10.1016/j.plefa.2003.07.006
13. Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, Pabinger I, Marosi C (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro-oncology 9:89-95. doi: 10.1215/15228517-2006-035
14. Den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3:292-299. doi: 10.1111/j.1538-7836.2005.01141.x
15. Amiel SA, Archibald HR, Chusney G, Williams AJ, Gale EA (1991) Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci (Lond) 81:189-194
16. Volek J, Phinney S, Forsythe C, Quann E, Wood R, Puglisi M, Kraemer W, Bibus D, Fernandez M, Feinman R (2009) Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 44:297-309. doi: 10.1007/s11745-008-3274-2
17. Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA (2012) Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 28(10):1028-1035. doi: 10.1016/j.nut.2012.05.001
18. Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL (2013) Nutrient restriction and radiation therapy for cancer treatment: when less is more. Oncologist 18:97-103. doi: 10.1634/theoncologist.2012-0164
19. Stafford P, Abdelwahab M, Kim D, Preul M, Rho J, Scheck A (2010) The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab 7:74
20. Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC (2012) The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE 7:e36197. doi: 10.1371/journal.pone. 0036197
21. Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, Seyfried T (2010) Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr Metab 7:33
22. Nebeling LC, Lerner E (1995) Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 95:693-697
23. Baserga R (2000) The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574-5581. doi: 10.1038/sj.onc.1203854
24. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54:4848-4850
25. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:311-320
26. Perer ES, Madan AK, Shurin A, Zakris E, Romeguera K, Pang Y, Beech DJ (2000) Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells. J Surg Res 94:1-5. doi: 10.1006/jsre.2000.5923S0022-4804(00)95923-7
27. Andrews DW, Resnicoff M, Flanders AE, Kenyon L, Curtis M, Merli G, Baserga R, Iliakis G, Aiken RD (2001) Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol 19:2189-2200
28. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM (1997) Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-3083
29. Champ CE, Volek JS, Siglin J, Jin L, Simone NL (2012) Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? Int J Breast Cancer 2012:9. doi: 10.1155/2012/506868
30. Klement RJ, Kammerer U (2011) Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 8:75. doi: 10.1186/1743-7075-8-75
31. Simone BA, Champ CE, Rosenberg AL, Berger AC, Monti DA, Dicker AP, Simone NL (2013) Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncol 9:959-976. doi: 10.2217/fon.13.31